BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30579125)

  • 1. Unprecedented inhibition of P-gp activity by a novel ruthenium-cyclopentadienyl compound bearing a bipyridine-biotin ligand.
    Côrte-Real L; Karas B; Gírio P; Moreno A; Avecilla F; Marques F; Buckley BT; Cooper KR; Doherty C; Falson P; Garcia MH; Valente A
    Eur J Med Chem; 2019 Feb; 163():853-863. PubMed ID: 30579125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methyl-cyclopentadienyl Ruthenium Compounds with 2,2'-Bipyridine Derivatives Display Strong Anticancer Activity and Multidrug Resistance Potential.
    Côrte-Real L; Teixeira RG; Gírio P; Comsa E; Moreno A; Nasr R; Baubichon-Cortay H; Avecilla F; Marques F; Robalo MP; Mendes P; Ramalho JPP; Garcia MH; Falson P; Valente A
    Inorg Chem; 2018 Apr; 57(8):4629-4639. PubMed ID: 29611696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
    Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB
    Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel "ruthenium cyclopentadienyl"-peptide conjugate complexes against human FGFR(+) breast cancer.
    Franco Machado J; Machuqueiro M; Marques F; Robalo MP; Piedade MFM; Garcia MH; Correia JDG; Morais TS
    Dalton Trans; 2020 May; 49(18):5974-5987. PubMed ID: 32314752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heteroleptic mononuclear compounds of ruthenium(ii): synthesis, structural analyses, in vitro antitumor activity and in vivo toxicity on zebrafish embryos.
    Lenis-Rojas OA; Fernandes AR; Roma-Rodrigues C; Baptista PV; Marques F; Pérez-Fernández D; Guerra-Varela J; Sánchez L; Vázquez-García D; Torres ML; Fernández A; Fernández JJ
    Dalton Trans; 2016 Dec; 45(47):19127-19140. PubMed ID: 27868117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel family of [RuCp(N,N)(P)]
    Teixeira RG; Mészáros JP; Matos B; Côrte-Real L; Xavier CPR; Fontrodona X; Garcia MH; Romero I; Spengler G; Vasconcelos MH; Tomaz AI; Enyedy ÉA; Valente A
    Eur J Med Chem; 2023 Dec; 262():115922. PubMed ID: 37944388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The key role of coligands in novel ruthenium(II)-cyclopentadienyl bipyridine derivatives: Ranging from non-cytotoxic to highly cytotoxic compounds.
    Côrte-Real L; Robalo MP; Marques F; Nogueira G; Avecilla F; Silva TJ; Santos FC; Tomaz AI; Garcia MH; Valente A
    J Inorg Biochem; 2015 Sep; 150():148-59. PubMed ID: 26150132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological assessment of a ruthenium(II) cyclopentadienyl complex in breast cancer cells and on the development of zebrafish embryos.
    Golbaghi G; Pitard I; Lucas M; Haghdoost MM; de Los Santos YL; Doucet N; Patten SA; Sanderson JT; Castonguay A
    Eur J Med Chem; 2020 Feb; 188():112030. PubMed ID: 31945643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the In Vitro and In Vivo Efficacy of Ruthenium Polypyridyl Compounds against Breast Cancer.
    Lenis-Rojas OA; Roma-Rodrigues C; Fernandes AR; Carvalho A; Cordeiro S; Guerra-Varela J; Sánchez L; Vázquez-García D; López-Torres M; Fernández A; Fernández JJ
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ruthenium-Cyclopentadienyl Bipyridine-Biotin Based Compounds: Synthesis and Biological Effect.
    Côrte-Real L; Karas B; Brás AR; Pilon A; Avecilla F; Marques F; Preto A; Buckley BT; Cooper KR; Doherty C; Garcia MH; Valente A
    Inorg Chem; 2019 Jul; 58(14):9135-9149. PubMed ID: 31241925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed-ligand ruthenium polypyridyl complexes as apoptosis inducers in cancer cells, the cellular translocation and the important role of ROS-mediated signaling.
    Zhao Z; Luo Z; Wu Q; Zheng W; Feng Y; Chen T
    Dalton Trans; 2014 Dec; 43(45):17017-28. PubMed ID: 25087850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclometalated ruthenium complexes overcome cisplatin resistance through PI3K/mTOR/Nrf2 signaling pathway.
    Chen L; Yu W; Tang H; Zhang S; Wang J; Ouyang Q; Guo M; Zhu X; Huang Z; Chen J
    Metallomics; 2024 Jan; 16(1):. PubMed ID: 38183290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic activity of Ru(II)/DPEPhos/N,S-mercapto complexes (DPEPhos = bis-[(2-diphenylphosphino)phenyl]ether).
    Grawe GF; Oliveira KM; Leite CM; de Oliveira TD; Costa AR; Moraes CAF; Honorato J; Cominetti MR; Castellano EE; Correa RS; Machado SP; Batista AA
    J Inorg Biochem; 2023 Jul; 244():112204. PubMed ID: 37004320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dinuclear Ru
    Lenis-Rojas OA; Roma-Rodrigues C; Fernandes AR; Marques F; Pérez-Fernández D; Guerra-Varela J; Sánchez L; Vázquez-García D; López-Torres M; Fernández A; Fernández JJ
    Inorg Chem; 2017 Jun; 56(12):7127-7144. PubMed ID: 28585811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Versatile ruthenium complexes based on 2,2'-bipyridine modified peptoids.
    Baskin M; Panz L; Maayan G
    Chem Commun (Camb); 2016 Aug; 52(68):10350-3. PubMed ID: 27349289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, Characterization, and in Vitro Antitumor Activity of Ruthenium(II) Polypyridyl Complexes Tethering EGFR-Inhibiting 4-Anilinoquinazolines.
    Du J; Kang Y; Zhao Y; Zheng W; Zhang Y; Lin Y; Wang Z; Wang Y; Luo Q; Wu K; Wang F
    Inorg Chem; 2016 May; 55(9):4595-605. PubMed ID: 27093574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxicity of Ru(II) piano-stool complexes with chloroquine and chelating ligands against breast and lung tumor cells: Interactions with DNA and BSA.
    Colina-Vegas L; Villarreal W; Navarro M; de Oliveira CR; Graminha AE; Maia PIDS; Deflon VM; Ferreira AG; Cominetti MR; Batista AA
    J Inorg Biochem; 2015 Dec; 153():150-161. PubMed ID: 26277415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ru(II)/clotrimazole/diphenylphosphine/bipyridine complexes: Interaction with DNA, BSA and biological potential against tumor cell lines and Mycobacterium tuberculosis.
    Colina-Vegas L; Dutra JL; Villarreal W; de A Neto JH; Cominetti MR; Pavan F; Navarro M; Batista AA
    J Inorg Biochem; 2016 Sep; 162():135-145. PubMed ID: 27383651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel ruthenium methylcyclopentadienyl complex bearing a bipyridine perfluorinated ligand shows strong activity towards colorectal cancer cells.
    Teixeira RG; Brás AR; Côrte-Real L; Tatikonda R; Sanches A; Robalo MP; Avecilla F; Moreira T; Garcia MH; Haukka M; Preto A; Valente A
    Eur J Med Chem; 2018 Jan; 143():503-514. PubMed ID: 29202411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ru(ii)-(PTA) and -mPTA complexes with N
    Wołoszyn A; Pettinari C; Pettinari R; Badillo Patzmay GV; Kwiecień A; Lupidi G; Nabissi M; Santoni G; Smoleński P
    Dalton Trans; 2017 Aug; 46(30):10073-10081. PubMed ID: 28731114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.